SUPPORTING TEAM INNOVATION WITH DESIGN THINKING COGNITIVE STRATEGIES

Innovation is a 21st-century skill needed to design new systems, solve challenging problems, and develop novel solutions. Design Thinking (DT) is a tool used to support team innovation. In this experiment, 145 students (47 teams) used one of two DT methods during a semester-long project to come up with an innovative solution to one of the UNESCO 17 sustainable development goals. The key experimental manipulation was during the DT Ideate phase where teams brainstormed potential solutions. Teams either used a baseline DT Ideate strategy or an expanded one with additional prompts during a 10-minute period. Results indicated that teams using the expanded DT Ideate strategy generated 57% more solutions than those in the baseline DT condition. The solutions were content analyzed for innovativeness and the final proposed solutions were rated by other teams. Implications for implementing design thinking are discussed

Readability of Instructional Materials and Usability of Online Learning Environment: Their Relations to the Development of Authentic and Contingent Knowledge

This research project correlates authentic knowledge with the readability of instructional materials and contingent knowledge with usability of the online learning environment. Based on thematic analyses in above two areas, we propose a model that governs how adult learners develop authentic and contingent knowledge in an intertwined manner

Makerspace Prototype Exploration for Local Micro-Business Incubator

This project is designed to hedge against further decline in our economy by creating the preconditions to help graduating high school seniors to create economic opportunities, innovate their way forward, connect with innovation and entrepreneurship resources and lead by example. Scope & Community Engagement Michigan Technological University's innovation and entrepreneurship resource hub, Husky Innovate, was approached by New Power Tour, Inc.(NPT-501c3), to build an economic support mechanism for our economically-challenged area of the Western U.P. Our partnership takes the form of a Houghton High School National Honor Society (HHSNHS) student-led pilot project that will familiarize students with the steps involved in building a business by participating in experiential learning exercises at each phase of an innovation. During this pilot project, students will engage in activities to understand opportunity recognition, prototyping, product-market-fit, brand definition, commercialization and sales. While students gain knowledge and experience as innovators, they will connect with resources within our local innovation and entrepreneurship ecosystem and strengthen community networks while simultaneously highlighting gaps to be addressed

Long-Term Mortality in Patients Diagnosed with Meningococcal Disease: A Danish Nationwide Cohort Study

Background: In contrast to the case fatality rate of patients diagnosed with meningococcal disease (MD) the long-term mortality in these patients is poorly documented. Methodology/Principal Findings: We performed a nationwide, population-based cohort study including all Danish patients diagnosed with MD from 1977 through 2006 and alive one year after diagnosis. Data was retrieved from the Danish National Hospital Register, the Danish Civil Registration System and the Danish Register of Causes of Death. For each patient four age- and gender-matched individuals were identified from the population cohort. The siblings of the MD patients and of the individuals from the population cohort were identified. We constructed Kaplan-Meier survival curves and used Cox regression analysis, cumulative incidence function and subdistribution hazard regression to estimate mortality rate ratios (MRR) and analyze causes of death. We identified 4,909 MD patients, 19,636 individuals from the population cohort, 8,126 siblings of MD patients and 31,140 siblings of the individuals from the population cohort. The overall MRR for MD patients was 1.27 (95 % confidence interval (CI), 1.12–1.45), adjusted MRR, 1.21 (95 % CI, 1.06–1.37). MD was associated with increased risk of death due to nervous system diseases (MRR 3.57 (95 % CI, 1.82–7.00). No increased mortality due to infections, neoplasms or cardiovascular diseases was observed. The MRR for siblings of MD patients compared with siblings of the individuals from the population cohort was 1.17 (95 % CI, 0.92–1.48)

Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation

The objective of this study was to compare letrozole-stimulated cycles to natural cycles in 208 patients undergoing intrauterine insemination (IUI) between July of 2004 and January of 2007. Group I (n = 47) received cycle monitoring only (natural group), Group II (n = 125) received letrozole 2.5 mg/day on cycle days three to seven, and Group III (n = 36) received letrozole 5 mg/day on cycle days three to seven. There were no differences between the groups in endometrial thickness or P4 on the day of hCG. Estradiol levels had higher variation in the second half of the follicular phase in both letrozole-treated groups compared to the control group. Estradiol per preovulatory follicle was similar in both letrozole cycles to that observed in the natural cycles. LH was lower on the day of hCG administration in the letrozole 2.5 mg/day group vs. the natural group. In summary, letrozole results in some minor changes in follicular, hormonal and endometrial dynamics compared to natural cycles. Increased folliculogenesis and pregnancy rates were observed in the letrozole-treated groups compared to the natural group. These findings need to be confirmed in larger, prospective studies

miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS.

ObjectiveOnset of multiple sclerosis (MS) occurs in childhood for approximately 5% of cases (pediatric MS, or ped-MS). Epigenetic influences are strongly implicated in MS pathogenesis in adults, including the contribution from microRNAs (miRNAs), small noncoding RNAs that affect gene expression by binding target gene mRNAs. Few studies have specifically examined miRNAs in ped-MS, but individuals developing MS at an early age may carry a relatively high burden of genetic risk factors, and miRNA dysregulation may therefore play a larger role in the development of ped-MS than in adult-onset MS. This study aimed to look for evidence of miRNA involvement in ped-MS pathogenesis.MethodsGWAS results from 486 ped-MS cases and 1362 controls from the U.S. Pediatric MS Network and Kaiser Permanente Northern California membership were investigated for miRNA-specific signals. First, enrichment of miRNA-target gene network signals was evaluated using MIGWAS software. Second, SNPs in miRNA genes and in target gene binding sites (miR-SNPs) were tested for association with ped-MS, and pathway analysis was performed on associated target genes.ResultsMIGWAS analysis showed that miRNA-target gene signals were enriched in GWAS (P = 0.038) and identified 39 candidate biomarker miRNA-target gene pairs, including immune and neuronal signaling genes. The miR-SNP analysis implicated dysregulation of miRNA binding to target genes in five pathways, mainly involved in immune signaling.InterpretationEvidence from GWAS suggests that miRNAs play a role in ped-MS pathogenesis by affecting immune signaling and other pathways. Candidate biomarker miRNA-target gene pairs should be further studied for diagnostic, prognostic, and/or therapeutic utility

B-cell targeting with anti-CD38 daratumumab:implications for differentiation and memory responses

B cell–targeted therapies, such as CD20-targeting mAbs, deplete B cells but do not target the autoantibody-producing plasma cells (PCs). PC-targeting therapies such as daratumumab (anti-CD38) form an attractive approach to treat PC-mediated diseases. CD38 possesses enzymatic and receptor capabilities, which may impact a range of cellular processes including proliferation and differentiation. However, very little is known whether and how CD38 targeting affects B-cell differentiation, in particular for humans beyond cancer settings. Using in-depth in vitro B-cell differentiation assays and signaling pathway analysis, we show that CD38 targeting with daratumumab demonstrated a significant decrease in proliferation, differentiation, and IgG production upon T cell–dependent B-cell stimulation. We found no effect on T-cell activation or proliferation. Furthermore, we demonstrate that daratumumab attenuated the activation of NF-?B in B cells and the transcription of NF-?B–targeted genes. When culturing sorted B-cell subsets with daratumumab, the switched memory B-cell subset was primarily affected. Overall, these in vitro data elucidate novel non-depleting mechanisms by which daratumumab can disturb humoral immune responses. Affecting memory B cells, daratumumab may be used as a therapeutic approach in B cell–mediated diseases other than the currently targeted malignancies